Buckminsterfullerene and photodynamic inactivation of viruses

Reviews in Medical Virology

Volumn 8, Issue 3, 1998, Pages 143-151

  Käsermann, Fabian ^a   Kempf, Christoph ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Central Laboratory in Bern   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FULLERENE; FULLERENE DERIVATIVE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

BLOOD; DISINFECTION; INSTRUMENT STERILIZATION; PHOTOSENSITIZATION; PHOTOTOXICITY; REVIEW; VIRUS INACTIVATION; VIRUS TRANSMISSION;

EID: 0031855132     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(199807/09)8:3<143::AID-RMV214>3.0.CO;2-B     Document Type: Review

References (5)

1. Sayers, M. H. (1994). Transfusion-transmitted viral infections other than hepatitis and human immunodeficiency virus infection: Cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and human parvovirus B19. Arch. Pathol, lab. Med. 118, 346-349.
2. Mosley, J. W. (1994). Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates? Transfusion 34, 744-746.
3. Roberts, P. (1996). Virus safety of plasma products. Rev. Med. Virol. 6, 25-38.
4. Suomela, H. (1993). Inactivation of viruses in blood and plasma products. Tranfus. Med. Rev. VII, 42-57.
5. Ben-Hur, E. and Horowitz, B. (1996). Virus inactivation in blood. AIDS 10, 1183-1190.